Jun 18, 2015 at 19:00 | Source: PTI
State-run power generation company NTPC will seek its board's nod on the takeover of Damodar Valley Corporation's Raghunathpur thermal power plant in West Bengal's Purulia district.
Jun 18, 2015 at 15:04 | Source: PTI
Cairn, which holds 30 percent interest in the Rajasthan block, wants to retain the Rajasthan block beyond the contractual deadline of 2020. And for such an extension the nod of the state-owned firm, which is a licence of the block holding 30 percent interest, was necessary.
Jun 18, 2015 at 11:41 | Source: Moneycontrol.com
The government approved proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent, Biocon's research services arm Syngene and two other firms.
Jun 18, 2015 at 10:12 | Source: Moneycontrol.com
"Orchid has received approval from the USFDA for the abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets (320 mg) with 180 days of generic drug exclusivity," said the drug maker in its filing.
Jun 17, 2015 at 18:50 | Source: PTI
The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets in the strength of 320 mg, Orchid Chemicals & Pharmaceuticals said in a filing to BSE.
Jun 17, 2015 at 17:56 | Source: CNBC-TV18
The entity will be named as Bandhan Bank. "We will launch the bank in Kolkata, where Bandhan is headquartered, on August 23," its Chairman and Managing Director Chandra Shekhar Ghosh told reporters here today.
Jun 16, 2015 at 11:18 | Source: Moneycontrol.com
Hyderabad-based Aurobindo Pharma has received the final approval from the USFDA to manufacture and market extended Phenytoin sodium capsules USP, 100mg.
Jun 16, 2015 at 10:21 | Source: Moneycontrol.com
Shares of Biocon gained 3 percent intraday Tuesday after its research subsidiary Syngene International has received an approval from the capital markets regulator SEBI to launch an initial public offer (IPO).
Jun 15, 2015 at 19:25 | Source: PTI
The company had filed its draft red herring prospectus (DRHP) with Sebi through its lead merchant banker Axis Capital in April.
Jun 15, 2015 at 17:46 | Source: PTI
Glenmark Pharmaceuticals USA has been granted final approval by the United States Food & Drug Administration (USFDA) for the "extended-cycle oral contraceptive Levonorgestrel and Ethinyl Estradiol tablets USP 0.15 mg/0.03 mg," Glenmark Pharmaceuticals said in a statement.